Torax Medical said in a regulatory filing that it has secured $4 million in debt financing and is looking to raise an additional $4 million. The Minnesota-based company already has filed a premarket approval application with the FDA for its Linx Anti-Reflux device, which currently is marketed in Europe.

Full Story:

Related Summaries